Genpharmasec Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 67.6 million compared to INR 24.15 million a year ago. Revenue was INR 67.76 million compared to INR 24.98 million a year ago. Net income was INR 2.2 million compared to INR 0.238 million a year ago. Basic earnings per share from continuing operations was INR 0.01. Diluted earnings per share from continuing operations was INR 0.01.
For the nine months, sales was INR 198.82 million compared to INR 145.47 million a year ago. Revenue was INR 199.63 million compared to INR 149.29 million a year ago. Net loss was INR 2.49 million compared to INR 11.09 million a year ago. Basic loss per share from continuing operations was INR 0.01 compared to INR 0.04 a year ago. Diluted loss per share from continuing operations was INR 0.01 compared to INR 0.04 a year ago.